The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Open accessAbstract
The immunogenicity of polysaccharides as human vaccines was enhanced by coupling to protein carriers. Conjugation transformed the T cell-independent polysaccharide vaccines of the past to T cell-dependent antigenic vaccines that were much more immunogenic and launched a renaissance in vaccinology. This review discusses the conjugate vaccines for prevention of infections caused by Hemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis. Specifically, the characteristics of the proteins used in the construction of the vaccines including CRM, tetanus toxoid, diphtheria toxoid, Neisseria meningitidis outer membrane complex, and Hemophilus influenzae protein D are discussed. The studies that established differences among and key features of conjugate vaccines including immunologic memory induction, reduction of nasopharyngeal colonization and herd immunity, and antibody avidity and avidity maturation are presented. Studies of dose, schedule, response to boosters, of single protein carriers with single and multiple polysaccharides, of multiple protein carriers with multiple polysaccharides and conjugate vaccines administered concurrently with other vaccines are discussed along with undesirable consequences of conjugate vaccines. The clear benefits of conjugate vaccines in improving the protective responses of the immature immune systems of young infants and the senescent immune systems of the elderly have been made clear and opened the way to development of additional vaccines using this technology for future vaccine products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Eerola, M., Haapakoski, J., Herva, E., Takala, A., Käyhty, H., Karma, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440602 · Cited by 1,455
Serotype replacement in disease after pneumococcal vaccination
Weinberger, D. M., Malley, R., & Lipsitch, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62225-8 · Cited by 1,020
Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., & Pierce, N. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035060 · Cited by 1,009
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Prymula, R., Peeters, P., Chrobok, V., Kriz, P., Novakova, E., Kaliskova, E., Kohl, I., Lommel, P., Poolman, J., Prieels, J.-P., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68304-9 · Cited by 637
Schneerson, R., Barrera, O., Sutton, A., & Robbins, J. B. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.2.361 · Cited by 625
Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
BLACK, S. B., SHINEFIELD, H. R., LING, S., HANSEN, J., FIREMAN, B., SPRING, D., NOYES, J., LEWIS, E., RAY, P., LEE, J., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200209000-00005 · Cited by 616
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571
Kayhty, R., Peltola, H., Karanko, V., & Makela, P. H. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.6.1100 · Cited by 542
Prymula, R., Peeters, P., Chrobok, V., Kriz, P., Novakova, E., Kaliskova, E., Kohl, I., Lommel, P., Poolman, J., Prieels, J., et al. (2006) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2006.01314.x · Cited by 522
Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999) · The Journal of Infectious Diseases · doi:10.1086/315009 · Cited by 515
Miller, E., Salisbury, D., & Ramsay, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 482
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442
Maiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 411
Mulholland, K., Hilton, S., Adegbola, R., Usen, S., Oparaugo, A., Omosigho, C., Weber, M., Palmer, A., Schneider, G., Jobe, K., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09267-7 · Cited by 406
Rennels, M. B., Edwards, K. M., Keyserling, H. L., Reisinger, K. S., Hogerman, D. A., Madore, D. V., Chang, I., Paradiso, P. R., Malinoski, F. J., & Kimura, A. (1998) · Pediatrics · doi:10.1542/peds.101.4.604 · Cited by 392
O'Brien, K. L., Moulton, L. H., Reid, R., Weatherholtz, R., Oski, J., Brown, L., Kumar, G., Parkinson, A., Hu, D., Hackell, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14022-6 · Cited by 388
Capsule switching of Neisseria meningitidis
Swartley, J. S., Marfin, A. A., Edupuganti, S., Liu, L.-J., Cieslak, P., Perkins, B., Wenger, J. D., & Stephens, D. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.271 · Cited by 383
Takala, A. K., Eskola, J., Leinonen, M., Kayhty, H., Nissinen, A., Pekkanen, E., & Makela, P. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.5.982 · Cited by 377
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
Avery, O. T., & Goebel, W. F. (1929) · Journal of Experimental Medicine · doi:10.1084/jem.50.4.533 · Cited by 374
Pichichero, M. E., & Casey, J. R. (2007) · JAMA · doi:10.1001/jama.298.15.1772 · Cited by 367
Self-citationHuang, S. S., Platt, R., Rifas-Shiman, S. L., Pelton, S. I., Goldmann, D., & Finkelstein, J. A. (2005) · Pediatrics · doi:10.1542/peds.2004-2338 · Cited by 344
Dagan, R., Givon‐Lavi, N., Zamir, O., Sikuler‐Cohen, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339525 · Cited by 339
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
Ramsay, M. E., Andrews, N., Kaczmarski, E. B., & Miller, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03594-7 · Cited by 338
Eskola, J., Käyhty, H., Takala, A. K., Peltola, H., Rönnberg, P.-R., Kela, E., Pekkanen, E., McVerry, P. H., & Mäkelä, P. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232004 · Cited by 333
Black, S., Shinefield, H., Baxter, R., Austrian, R., Bracken, L., Hansen, J., Lewis, E., & Fireman, B. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129685.04847.94 · Cited by 324
Santosham, M., Wolff, M., Reid, R., Hohenboken, M., Bateman, M., Goepp, J., Cortese, M., Sack, D., Hill, J., Newcomer, W., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106203242503 · Cited by 283
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
Goebel, W. F., & Avery, O. T. (1929) · Journal of Experimental Medicine · doi:10.1084/jem.50.4.521 · Cited by 283
Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Huang, S. S., Hinrichsen, V. L., Stevenson, A. E., Rifas-Shiman, S. L., Kleinman, K., Pelton, S. I., Lipsitch, M., Hanage, W. P., Lee, G. M., & Finkelstein, J. A. (2009) · Pediatrics · doi:10.1542/peds.2008-3099 · Cited by 269
Vesikari, T., Wysocki, J., Chevallier, B., Karvonen, A., Czajka, H., Arsène, J.-P., Lommel, P., Dieussaert, I., & Schuerman, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318199f8ef · Cited by 268
Eskola, J., Peltola, H., Takala, A. K., Käyhty, H., Hakulinen, M., Karanko, V., Kela, E., Rekola, P., Rönnberg, P.-R., Samuelson, J. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171201 · Cited by 258
Hammitt, L. L., Bruden, D. L., Butler, J. C., Baggett, H. C., Hurlburt, D. A., Reasonover, A., & Hennessy, T. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/503805 · Cited by 254
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
Giannini, G., Rappuoli, R., & Ratti, G. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.10.4063 · Cited by 251
MacDonald, N. E., Halperin, S. A., Law, B. J., Forrest, B., Danzig, L. E., & Granoff, D. M. (1998) · JAMA · doi:10.1001/jama.280.19.1685 · Cited by 250
Kilpi, T., Ahman, H., Jokinen, J., Lankinen, K. S., Palmu, A., Savolainen, H., Gronholm, M., Leinonen, M., Hovi, T., Eskola, J., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378744 · Cited by 244
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
BLACK, S. B., SHINEFIELD, H. R., HANSEN, J., ELVIN, L., LAUFER, D., & MALINOSKI, F. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200112000-00002 · Cited by 242
Dagan, R., Eskola, J., Leclerc, C., & Leroy, O. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2093-2098.1998 · Cited by 242
Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory
Richmond, P., Borrow, R., Miller, E., Clark, S., Sadler, F., Fox, A., Begg, N., Morris, R., & Cartwright, K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314753 · Cited by 240
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Yeh, S. H., Gurtman, A., Hurley, D. C., Block, S. L., Schwartz, R. H., Patterson, S., Jansen, K. U., Love, J., Gruber, W. C., Emini, E. A., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-3027 · Cited by 233
Generation and maintenance of immunological memory
Gourley, T. S., Wherry, E. J., Masopust, D., & Ahmed, R. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.013 · Cited by 231
Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines
Decker, M. D., Edwards, K. M., Bradley, R., & Palmer, P. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80424-x · Cited by 228
Palmu, A. A., Jokinen, J., Borys, D., Nieminen, H., Ruokokoski, E., Siira, L., Puumalainen, T., Lommel, P., Hezareh, M., Moreira, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61854-6 · Cited by 224
Gray, S. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46288-0 · Cited by 221
Carrier-priming leads to hapten-specific suppression
Herzenberg, L. A., Tokuhisa, T., & Herzenberg, L. A. (1980) · Nature · doi:10.1038/285664a0 · Cited by 220
Richmond, P., Borrow, R., Goldblatt, D., Findlow, J., Martin, S., Morris, R., Cartwright, K., & Miller, E. (2001) · The Journal of Infectious Diseases · doi:10.1086/317646 · Cited by 219
Goldblatt, D., Vaz, A. R. J. P. M. P., & Miller, E. (1998) · The Journal of Infectious Diseases · doi:10.1086/517407 · Cited by 218
DAGAN, R., MUALLEM, M., MELAMED, R., LEROY, O., & YAGUPSKY, P. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199711000-00011 · Cited by 217
Snape, M. D., Perrett, K. P., Ford, K. J., John, T. M., Pace, D., Yu, L.-M., Langley, J. M., McNeil, S., Dull, P. M., Ceddia, F., et al. (2008) · JAMA · doi:10.1001/jama.2007.29-c · Cited by 217
Richter, S. S., Heilmann, K. P., Dohrn, C. L., Riahi, F., Diekema, D. J., & Doern, G. V. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1907.121830 · Cited by 214
Haemophilus influenzae type b conjugate vaccines
Kelly, D. F., Moxon, E. R., & Pollard, A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01971.x · Cited by 214
Juanita Zamorano, R. (2003) · Revista chilena de infectología · doi:10.4067/s0716-10182003000300010 · Cited by 211
Schlesinger, Y. (1992) · JAMA · doi:10.1001/jama.267.11.1489 · Cited by 207
Leach, A., Twumasi, P. A., Kumah, S., Banya, W. S., Jaffar, S., Forrest, B. D., Granoff, D. M., LiButti, D. E., Carlone, G. M., Pais, L. B., et al. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.1.200 · Cited by 206
MacLennan, J. M., Shackley, F., Heath, P. T., Deeks, J. J., Flamank, C., Herbert, M., Griffiths, H., Hatzmann, E., Goilav, C., & Moxon, E. R. (2000) · JAMA · doi:10.1001/jama.283.21.2795 · Cited by 199
McVernon, J., Andrews, N., Slack, M., & Ramsay, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13171-6 · Cited by 193
Limited Efficacy of a Haemophilus influenzae Type b Conjugate Vaccine in Alaska Native Infants
Ward, J., Brenneman, G., Letson, G. W., & Heyward, W. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232006 · Cited by 189
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Bryant, K. A., Block, S. L., Baker, S. A., Gruber, W. C., Scott, D. A., & for the PCV13 Infant Study Group (2010) · Pediatrics · doi:10.1542/peds.2009-1405 · Cited by 186
Cohen, R., Levy, C., Bingen, E., Koskas, M., Nave, I., & Varon, E. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318247ef84 · Cited by 182
Ghaffar, F., Barton, T., Lozano, J., Muniz, L. S., Hicks, P., Gan, V., Ahmad, N., & McCracken, Jr. (2004) · Clinical Infectious Diseases · doi:10.1086/423379 · Cited by 175
Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172
Usinger, W. R., & Lucas, A. H. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2366-2370.1999 · Cited by 171
Halperin, B. A., Morris, A., MacKinnon-Cameron, D., Mutch, J., Langley, J. M., McNeil, S. A., MacDougall, D., & Halperin, S. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir538 · Cited by 164
Goldblatt, D., Southern, J., Ashton, L., Richmond, P., Burbidge, P., Tasevska, J., Crowley-Luke, A., Andrews, N., Morris, R., Borrow, R., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000207483.60267.e7 · Cited by 162
Cohen, R., Levy, C., de La Rocque, F., Gelbert, N., Wollner, A., Fritzell, B., Bonnet, E., Tetelboum, R., & Varon, E. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000243163.85163.a8 · Cited by 158
Dagan, R., Givon‐Lavi, N., Zamir, O., & Fraser, D. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000069761.11093.c3 · Cited by 158
KEYSERLING, H. L., Papa, T., Koranyi, K., Ryall, R., Bassily, E. L., Bybel, M. J., Sullivan, K., Gilmet, G., & Reinhardt, A. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.10.907 · Cited by 156
Millar, E. V., Watt, J., Bronsdon, M. A., Dallas, J. H., Reid, R., Santosham, M., & O’Brien, K. L. (2008) · Clinical Infectious Diseases · doi:10.1086/591966 · Cited by 154
Dagan, R., Givon‐Lavi, N., Fraser, D., Lipsitch, M., Siber, G. R., & Kohberger, R. C. (2005) · The Journal of Infectious Diseases · doi:10.1086/431679 · Cited by 153
Novel vaccine strategies to T-independent antigens
Lesinski, G. B., & Westerink, M. A. J. (2001) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(01)00290-1 · Cited by 151
Fairley, C. K., Begg, N. T., Borrow, R., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1360 · Cited by 151
A surveillance network for meningococcal disease in Europe
Trotter, C. L., Chandra, M., Cano, R., Larrauri, A., Ramsay, M. E., Brehony, C., Jolley, K. A., Maiden, M. C. J., Heuberger, S., & Frosch, M. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00060.x · Cited by 149
Esposito, S., Tansey, S. P., Thompson, A., Razmpour, A., Liang, J. Z., Jones, T. R., Ferrera, G., Maida, A., Bona, G., Sabatini, C., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00062-10 · Cited by 146
Lazarus, R., Clutterbuck, E., Yu, L., Bowman, J., Bateman, E. A. L., Diggle, L., Angus, B., Peto, T., Beverley, P. C. L., Mant, D., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir003 · Cited by 145
Auckland, C., Gray, S., Borrow, R., Andrews, N. J., Goldblatt, D., Ramsay, M. E., & Miller, E. (2006) · The Journal of Infectious Diseases · doi:10.1086/509619 · Cited by 143
Anderson, P. W., Pichichero, M. E., Insel, R. A., Betts, R. F., Eby, R., & Smith, D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.4.1181 · Cited by 141
Self-citationImmunogenicity of heptavalent pneumococcal conjugate vaccine in infants
Anderson, E. L., Kennedy, D. J., Geldmacher, K. M., Donnelly, J., & Mendelman, P. M. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)80130-2 · Cited by 141
Heath, P. T. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.6.396 · Cited by 139
Granoff, D. M., Anderson, E. L., Osterholm, M. T., Holmes, S., McHugh, J. E., Belshe, R. B., MEDLEY, F. B., & Murphy, T. V. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81186-2 · Cited by 134
Cordonnier, C., Labopin, M., Chesnel, V., Ribaud, P., de la Cámara, R., Martino, R., Ullmann, A. J., Parkkali, T., Locasciulli, A., Yakouben, K., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598324 · Cited by 134
Antibody Concentration and Clinical Protection After Hib Conjugate Vaccination in the United Kingdom
Heath, P. T. (2000) · JAMA · doi:10.1001/jama.284.18.2334 · Cited by 133
Einhorn, M. S., Anderson, E. L., Weinberg, G. A., Granoff, P. D., & Granoff, D. M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90001-2 · Cited by 132
Åhman, H., Käyhty, H. M., Lehtonen, H., Leroy, O. Y., Froeschle, J. E., & Eskola, J. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199803000-00008 · Cited by 131
van den Bergh, M. R., Spijkerman, J., Swinnen, K., François, N., Pascal, T. G., Borys, D., Schuerman, L., IJzerman, E. P. F., Bruin, J. P., ENDE, A. V. D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis922 · Cited by 131
de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & ENDE, A. V. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000195594.41449.c6 · Cited by 130
Kumar, D., Rotstein, C., Miyata, G., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/374784 · Cited by 130
Moore, M. R., Hyde, T. B., Hennessy, T. W., Parks, D. J., Reasonover, A. L., Harker‐Jones, M., Gove, J. E., Bruden, D. L., Rudolph, K. M., Parkinson, A. J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/425422 · Cited by 128
Snape, M. D., Klinger, C. L., Daniels, E. D., John, T. M., Layton, H., Rollinson, L., Pestridge, S., Dymond, S., Galiza, E. P., Tansey, S. P., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181faa6be · Cited by 126
BYSSINOSIS AND ATMOSPHERIC POLLUTION
Dollery, C. T., Hill, D. W., MAILER, C. M., & RAMALHO, P. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)93057-0 · Cited by 123
Carrier-induced epitopic suppression is initiated through clonal dominance.
Schutze, M. P., Dériaud, E., Przewlocki, G., & Leclerc, C. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.8.2635 · Cited by 121
Anderson, P. W., Pichichero, M. E., Stein, E., Porcelli, S., Betts, R. F., Connuck, D., Korones, D., Insel, R. A., Zahradnik, J. M., & Eby, R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.7.2464 · Cited by 119
Self-citationAnderson, P., Pichichero, M. E., & Insel, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111976 · Cited by 119
Self-citationChan, C. Y., Molrine, D. C., George, S., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.256 · Cited by 118
Shelly, M., Jacoby, H., Riley, G. J., Graves, B. T., Pichichero, M. E., & Treanor, J. J. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.242-247.1997 · Cited by 118
Self-citationMarburg, S., Jorn, D., Tolman, R. L., Arison, B., McCauley, J. P., Kniskern, P. J., Hagopian, A., & Vella, P. P. (1986) · Journal of the American Chemical Society · doi:10.1021/ja00277a037 · Cited by 117
Givon‐Lavi, N., Fraser, D., & Dagan, R. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000069760.65826.f2 · Cited by 117
Borrow, R., Andrews, N. J., Findlow, H., Waight, P., Southern, J., Crowley-Luke, A., Stapley, L., England, A., Findlow, J., & Miller, E. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00384-09 · Cited by 115
Borrow, R., Goldblatt, D., Andrews, N. J., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K. A. V., & Miller, E. (2002) · The Journal of Infectious Diseases · doi:10.1086/344324 · Cited by 114
Next generation pneumococcal vaccines
Moffitt, K. L., & Malley, R. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.04.002 · Cited by 113
Granoff, D. M., Holmes, S., Osterholm, M. T., McHugh, J. E., Lucas, A. H., Anderson, E. L., Belshe, R. B., Jacobs, J. L., MEDLEY, F. B., & MURPHY, T. V. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.663 · Cited by 112
Rohner, G. B., Snape, M. D., Kelly, D. F., John, T. M., Morant, A., Yu, L., Borkowski, A., Ceddia, F., Borrow, R., Siegrist, C., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2165 · Cited by 111
Jackson, L. A., Baxter, R. P., Reisinger, K. S., Karsten, A., Shah, J., Bedell, L., Dull, P. M., & the V59P13 Study Group (2009) · Clinical Infectious Diseases · doi:10.1086/599117 · Cited by 107
Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults
Anderson, E. L., Bowers, T., Mink, C. M., Kennedy, D. J., Belshe, R. B., Harakeh, H. S., Pais, L. B., Holder, P. F., & Carlone, G. M. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3391-3395.1994 · Cited by 107
Booster Vaccinations: Can Immunologic Memory Outpace Disease Pathogenesis?
Pichichero, M. E. (2009) · PEDIATRICS · doi:10.1542/peds.2008-3645 · Cited by 106
Self-citationO’Brien, K. L., Steinhoff, M. C., Edwards, K. M., KEYSERLING, H. L., THOMS, M. L., & Madore, D. V. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199605000-00009 · Cited by 106
Takala, A. K., Santosham, M., Almeido-Hill, J., Wolff, M. S., Newcomer, W., Reid, R., Käyhty, H. M., Esko, E., & Mäkelä, P. H. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199307000-00010 · Cited by 104
Borrow, R., Goldblatt, D., Finn, A. H. R., Southern, J., Ashton, L., Andrews, N. J., Lal, G., Riley, C., Rahim, R., Cartwright, K. A. V., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5549-5555.2003 · Cited by 103
Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine
Wals, P. D. (2004) · JAMA · doi:10.1001/jama.292.20.2491 · Cited by 101
Trotter, C. L., Ramsay, M. E., & Slack, M. (2003) · PubMed · Cited by 99
Immunologic Memory 5 Years after Meningococcal A/C Conjugate Vaccination in Infancy
MacLennan, J. M., Obaro, S., Deeks, J. J., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317667 · Cited by 99
Østergaard, L. J., Lebacq, E., POOLMAN, J. T., Maechler, G., & Boutriau, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.075 · Cited by 98
Fattom, A., Cho, Y. H., Chu, C., Fuller, S. A., Fries, L. F., & Naso, R. B. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00162-5 · Cited by 98
Carriage ofStreptococcus pneumoniae3 Years after Start of Vaccination Program, the Netherlands
Spijkerman, J., van Gils, E. J. M., Veenhoven, R. H., Hak, E., Yzerman, F., ENDE, A. V. D., Wijmenga‐Monsuur, A. J., van den Dobbelsteen, G. P. J. M., & Sanders, E. A. M. (2011) · Emerging infectious diseases · doi:10.3201/eid1704101115 · Cited by 95
BULKOW, L. R., Wainwright, R. B., Letson, G. W., Chang, S.-J., & Ward, J. I. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199306000-00006 · Cited by 94
Zepp, F., Schmitt, H.-J., Kaufhold, A., Schuind, A., Knuf, M., Habermehl, P., Meyer, C. U., Bogaerts, H. H., Slaoui, M., & Clemens, R. L. (1996) · European Journal of Pediatrics · doi:10.1007/s004310050544 · Cited by 92
Daum, R. S., HOGERMAN, D. A., Rennels, M. B., Bewley, K., Malinoski, F. J., Rothstein, E. P., Reisinger, K. S., Block, S. L., KEYSERLING, H. L., & Steinhoff, M. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/514063 · Cited by 92
Burrage, M., Robinson, A., Borrow, R., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4946-4954.2002 · Cited by 91
Lucas, A. H., & Granoff, D. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.4195 · Cited by 89
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
Haber, M., Barskey, A. E., Baughman, W. S., Barker, L. E., Whitney, C. G., Shaw, K. M., Orenstein, W. A., & Stephens, D. S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.088 · Cited by 89
Gill, C. J., Baxter, R. P., Anemona, A., Ciavarro, G., & Dull, P. M. (2010) · Human Vaccines · doi:10.4161/hv.6.11.12849 · Cited by 88
Singleton, R. J., Hammitt, L. L., Hennessy, T., BULKOW, L. R., DeByle, C. K., Parkinson, A. J., Cottle, T. E., Peters, H. V., & Butler, J. C. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0287 · Cited by 88
Dagan, R., Goldblatt, D., Maleckar, J. R., Yaïch, M., & Eskola, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5383-5391.2004 · Cited by 88
Anderson, P. W., Pichichero, M. E., & Insel, R. A. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80504-7 · Cited by 87
Self-citationBarington, T., Skettrup, M., Juul, L., & Heilmann, C. J. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.432-438.1993 · Cited by 86
Nurkka, A., HMAN, H., Korkeila, M., NTTI, V. J., YHTY, H. K., & Eskola, J. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00006 · Cited by 86
Campbell, J. D., Edelman, R., King, J. C., Papa, T., Ryall, R., & Rennels, M. B. (2002) · The Journal of Infectious Diseases · doi:10.1086/345763 · Cited by 86
Snape, M. D., Kelly, D. F., Salt, P., Green, S., Snowden, C., Diggle, L., Borkowski, A., Yu, L., Moxon, E. R., & Pollard, A. J. (2006) · Clinical Infectious Diseases · doi:10.1086/508776 · Cited by 86
Fernández, J., Levine, O. S., Sánchez, J., Balter, S. E., LaClaire, L. L., Feris, J. M., Romero‐Steiner, S., & the Hib Vaccine Evaluation Team (2000) · The Journal of Infectious Diseases · doi:10.1086/315870 · Cited by 86
Reisinger, K. S., Baxter, R. P., Block, S. L., Shah, J., Bedell, L., & Dull, P. M. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00207-09 · Cited by 86
Arguedas, A. G., Soley, C., Loaiza, C., Rincon, G., Guevara, S., Perez, A., Porras, W., Alvarado, O., Aguilar, L., Abdelnour, A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.045 · Cited by 85
Musher, D. M., Rueda, A. M., Nahm, M. H., Graviss, E. A., & Rodriguez‐Barradas, M. C. (2008) · The Journal of Infectious Diseases · doi:10.1086/591629 · Cited by 84
Wuorimaa, T., Dagan, R., Väkeväinen, M., Bailleux, F., Haikala, R., Yaïch, M., Eskola, J., & Käyhty, H. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/323648 · Cited by 83
Perrett, K. P., Winter, A. P., Kibwana, E., Jin, C., John, T. M., Yu, L., Borrow, R., Curtis, N. C., & Pollard, A. J. (2010) · Clinical Infectious Diseases · doi:10.1086/652765 · Cited by 83
Sharma, D., Baughman, W. S., Holst, A., Thomas, S., Jackson, D. M., Carvalho, M. D. G., Beall, B., Satola, S. W., Jerris, R. R., Jain, S., et al. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182788fdd · Cited by 82
King, J. C., Vink, P., Farley, J. J., Smilie, M., Parks, M. G., & Lichenstein, R. (1997) · PEDIATRICS · doi:10.1542/peds.99.4.575 · Cited by 80
Knuf, M., Kieninger‐Baum, D., Habermehl, P., Muttonen, P., Maurer, H., Vink, P., POOLMAN, J. T., & Boutriau, D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.064 · Cited by 79
Nachman, S., Kim, S., King, J. C., et al. (2003) · PEDIATRICS · doi:10.1542/peds.112.1.66 · Cited by 79
Cheung, Y., Zaman, S. M. A., Nsekpong, D. E., Beneden, C. V., Adegbola, R. A., Greenwood, B. M., & Cutts, F. T. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a78185 · Cited by 78
Anttila, M. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00458-7 · Cited by 78
The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
Bettinger, J. A., Scheifele, D. W., Saux, N. L., Halperin, S. A., Vaudry, W., & Tsang, R. S. W. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819040e7 · Cited by 76
Jackson, L. A., Jacobson, R. M., Reisinger, K. S., Anemona, A., Danzig, L. E., & Dull, P. M. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818a0237 · Cited by 76
Goldblatt, D., Richmond, P., Millard, E., Thornton, C., & Miller, E. (1999) · The Journal of Infectious Diseases · doi:10.1086/314901 · Cited by 76
Miernyk, K. M., Butler, J. C., BULKOW, L. R., Singleton, R. J., Hennessy, T. W., Dentinger, C., Peters, H. V., Knutsen, B., Hickel, J., & Parkinson, A. J. (2009) · Clinical Infectious Diseases · doi:10.1086/599824 · Cited by 75
Prymula, R., Hanovcová, I., Špliňo, M., Kriz, P., Motlová, J., Lebedova, V., Lommel, P., Kaliskova, E., Pascal, T. G., Borys, D., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.086 · Cited by 74
Weinberg, G. A., Einhorn, M. S., Lenoir, A. A., Granoff, P. D., & Granoff, D. M. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80336-0 · Cited by 74
Millar, E. V., O’Brien, K. L., Bronsdon, M. A., Madore, D. V., Hackell, J. G., Reid, R., & Santosham, M. (2007) · Clinical Infectious Diseases · doi:10.1086/513199 · Cited by 73
Lee, Y. C., Kelly, D. F., Yu, L., Slack, M., Booy, R., Heath, P. T., Siegrist, C., Moxon, R. E., & Pollard, A. J. (2007) · Clinical Infectious Diseases · doi:10.1086/524668 · Cited by 71
Baxter, R. P., Baine, Y., Ensor, K., Bianco, V., Friedland, L. R., & Miller, J. M. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182054ab9 · Cited by 69
Moulton, L. H., Chung, S.-E., Croll, J., Reid, R., Weatherholtz, R., & Santosham, M. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.753 · Cited by 68
Antibody Responses to Four Haemophilus influenzae Type b Conjugate Vaccines
Käyhty, H. M. (1991) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1991.02160020117030 · Cited by 64
Bermal, N., Huang, L., Dubey, A., Jain, H., Bavdekar, A., Lin, T., Bianco, V., Baine, Y., & Miller, J. M. (2011) · Human Vaccines · doi:10.4161/hv.7.2.14068 · Cited by 64
Klein, N. P., Reisinger, K. S., Johnston, W., Odrljin, T., Gill, C. J., Bedell, L., & Dull, P. M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31823dce5c · Cited by 63
Perrett, K. P., Snape, M. D., Ford, K. J., John, T. M., Yu, L., Langley, J. M., McNeil, S., Dull, P. M., Ceddia, F., Anemona, A., et al. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818e037d · Cited by 59
Laboratory Correlates of Protection against Haemophilus influenzae Type b Disease
Granoff, D. M., & Lucas, A. H. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44461.x · Cited by 58
Pina, L. M., Bassily, E. L., Machmer, A., Hou, V., & Reinhardt, A. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318268dfe4 · Cited by 58
Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine
MacNeil, J. R., Cohn, A. C., Zell, E. R., Schmink, S. E., Miller, E. R., Clark, T. A., & Messonnier, N. E. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820a8b3c · Cited by 58
Dagan, R., Käyhty, H. M., Wuorimaa, T., Yaïch, M., Bailleux, F., Zamir, O., & Eskola, J. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000109221.50972.53 · Cited by 56
Griffiths, U. K., Clark, A. D., Gessner, B. D., Miners, A. H., Sanderson, C. F. B., Sedyaningsih, E. R., & Mulholland, K. E. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812000957 · Cited by 56
Memish, Z. A., Dbaibo, G. S., Montellano, M., Verghese, V. P., Jain, H., Dubey, A. P., Bianco, V., der Wielen, M. V., GATCHALIAN, S. R., & Miller, J. M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820e6e02 · Cited by 55
Vanderkooi, O. G., Scheifele, D. W., Girgenti, D., Halperin, S. A., Patterson, S. D., Gruber, W. C., Emini, E. A., Scott, D. A., & Kellner, J. D. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318233049d · Cited by 55
BLACK, S. B., Klein, N. P., Shah, J., Bedell, L., Karsten, A., & Dull, P. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.104 · Cited by 54
Stamboulián, D., Lopardo, G. D., López, P., Cortes-Barbosa, C., Valencia, A., Bedell, L., Karsten, A., & Dull, P. M. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.03.017 · Cited by 52
Madhi, S. A., Klugman, K. P., Kuwanda, L., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597388 · Cited by 52
Effectiveness of Serogroup C Meningococcal Conjugate Vaccine
Wals, P. D., Deceuninck, G., Lefebvre, B., Boulianne, N., & Serres, G. D. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820e8638 · Cited by 52
Anderson, P. W., Ingram, D. L., Pichichero, M. E., & Peter, G. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200007000-00001 · Cited by 51
Self-citationMiernyk, K. M., Parkinson, A. J., Rudolph, K. M., Petersen, K. M., BULKOW, L. R., Greenberg, D. P., Ward, J. I., Brenneman, G., Reid, R., & Santosham, M. (2000) · Clinical Infectious Diseases · doi:10.1086/313907 · Cited by 49
Nieminen, T., Käyhty, H. M., LEROY, O., et al. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199909000-00005 · Cited by 49
Carrier-Induced, Hapten-Specific Suppression: A Problem of Antigen Presentation?
Renjifo, X., Wolf, S. F., Pastoret, P.-P., Bazin, H., Urbain, J., Léo, O., & Moser, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.702 · Cited by 49
Peltola, H. (1994) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1994.02170060074015 · Cited by 48
Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region
Booy, R. (1992) · The Lancet · doi:10.1016/0140-6736(92)92719-v · Cited by 48
Nurkka, A., Åhman, H., Yaïch, M., Eskola, J., & Käyhty, H. M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00250-x · Cited by 46
Gasparini, R., Conversano, M., Bona, G., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00436-09 · Cited by 45
Denoël, P., Goldblatt, D., de Vleeschauwer, I., Jacquet, J., Pichichero, M. E., & POOLMAN, J. T. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00154-07 · Cited by 44
Self-citationRennels, M. B., Englund, J. A., Bernstein, D. I., Losonsky, G. A., Anderson, E. L., Pichichero, M. E., Muñoz, F. M., & Wolff, M. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200005000-00006 · Cited by 43
Self-citationFinn, A. H. R., Zhang, Q., Seymour, L., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/344356 · Cited by 40
A mucosal antibody response following systemic Haemophilus influenzae type B infection in children.
Pichichero, M. E., Hall, C. B., & Insel, R. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110178 · Cited by 40
Self-citationKauppi-Korkeila, M., van Alphen, L., Madore, D. V., Saarinen, L., & Käyhty, H. M. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1337 · Cited by 40
Halperin, S. A., Díaz‐Mitoma, F., Dull, P. M., Anemona, A., & Ceddia, F. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0848-8 · Cited by 38
Capsular Gene Sequences and Genotypes of “Serotype 6E” Streptococcus pneumoniae Isolates
Ko, K. S., Baek, J. Y., & Song, J. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01645-13 · Cited by 38
Dbaibo, G. S., Macalalad, N. G., Reyes, M. R. A.-D. L., Dimaano, E. M., Bianco, V., Baine, Y., & Miller, J. M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.20211 · Cited by 37
Granoff, D. M., & Harris, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129686.12470.e6 · Cited by 37
Dunais, B., Bruno, P., Carsenti-Dellamonica, H., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817bb8cf · Cited by 37
Granoff, D. M., Morgan, A., & Welsch, J. A. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000151035.64356.f8 · Cited by 34
Vesikari, T., Forstén, A., Boutriau, D., Bianco, V., der Wielen, M. V., & Miller, J. M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22165 · Cited by 33
Daum, R. S., Siber, G. R., Ballanco, G. A., & Sood, S. K. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.6.1154 · Cited by 30
Lucero, M., Puumalainen, T., Ugpo, J., Williams, G. M., Käyhty, H. M., & Nohynek, H. (2004) · The Journal of Infectious Diseases · doi:10.1086/420849 · Cited by 29
McVernon, J., MacLennan, J. M., Pollard, A. J., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000076386.52719.b3 · Cited by 26
Nolan, T. M., Richmond, P., Marshall, H. S., McVernon, J., Alexander, K., Mesaros, N. E., Aris, E., Miller, J. M., POOLMAN, J. T., & Boutriau, D. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181fcb2bf · Cited by 26
Tregnaghi, M., Zambrano, B., & Lima, E. C. S. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318242460a · Cited by 24
Pichichero, M. E., Papa, T., Blatter, M. M., Mitchell, D., Kratz, R., Sneed, J., Bassily, E. L., Casey, J. R., & Gilmet, G. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000243215.46312.4a · Cited by 22
Self-citationBarington, T., Kristensen, K., Henrichsen, J., & Heilmann, C. J. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1057-1064.1991 · Cited by 22
Amdekar, Y. K., Lalwani, S. K., Bavdekar, A., Balasubramanian, S., Chhatwal, J., Bhat, S. R., Verghese, V. P., Tansey, S. P., Gadgil, D. A., Jiang, Q. L., et al. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31827b478d · Cited by 21
Knuf, M., Pankow-Culot, H., Grunert, D., Rapp, M., Panzer, F., Köllges, R., Fanic, A., Habib, A., Borys, D., Dieussaert, I., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182323ac2 · Cited by 20
Wals, P. D., Deceuninck, G., Serres, G. D., Boivin, J., Duval, B., Remis, R. S., & Massé, R. (2005) · Clinical Infectious Diseases · doi:10.1086/428729 · Cited by 20
McVernon, J., Nolan, T. M., Richmond, P., Reynolds, G., Nissen, M. D., Lambert, S. B., Marshall, H. S., Papa, T., & Rehm, C. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31823e1e34 · Cited by 14
Cited by
Understanding modern-day vaccines: what you need to know
Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1407035 · Cited by 354
Application of built-in adjuvants for epitope-based vaccines
Lei, Y., Zhao, F., Shao, J., Li, Y., Li, S., Chang, H., & Zhang, Y. (2019) · PeerJ · doi:10.7717/peerj.6185 · Cited by 115
Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
Novak, P., Kontsekova, E., Zilka, N., & Novak, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00798 · Cited by 87
“, tetanus toxoid (Pichichero, 2013), or artificial carriers that feature a broad spectrum of T-cell epitopes from various antigens (Davtyan et al.”
BackgroundInnovative Vaccine Strategy: Self-Adjuvanting Conjugate Vaccines
Manabe, Y., & Fukase, K. (2023) · Methods in Molecular Biology · doi:10.1007/978-1-0716-2910-9_5 · Cited by 5
Engineering intramolecular adjuvants for next-generation vaccines
Wang, Y., Liao, W., Zhang, Z., Wang, T., Zhang, J., Zai, X., & Xu, J. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100258
Metadata
- Authors
- Pichichero, M. E.
- Venue
- Human vaccines & immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2013-12-01
- Volume
- 9
- Issue
- 12
- Pages
- 2505-2523
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- OpenAlex
- W2026167111
- Cited by
- 261
- References
- 202
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.